1. Extracellular vesicles cargo from head and neck cancer cell lines disrupt dendritic cells function and match plasma microRNAs
- Author
-
Luciana Cavalheiro Marti, Martin Hoberman, Elisangela de Paula Silva, Alessandro Marins dos Santos, Larissa Figueiredo Alves Diniz, Romário Oliveira de Sales, Barbara dos Santos Dias, Eloiza H. Tajara, Flavia Maziero Andreghetto, Rossana Verónica Mendoza López, Raquel Ajub Moyses, Fábio Daumas Nunes, Patrícia Severino, and Otávio Alberto Curioni
- Subjects
Molecular biology ,media_common.quotation_subject ,Science ,Biology ,Article ,Extracellular Vesicles ,Immune system ,Cell Line, Tumor ,microRNA ,medicine ,Humans ,Internalization ,media_common ,Cancer ,Multidisciplinary ,Molecular medicine ,Head and neck cancer ,Biological techniques ,Dendritic cell ,Dendritic Cells ,medicine.disease ,Head and neck squamous-cell carcinoma ,Gene Expression Regulation, Neoplastic ,MicroRNAs ,Cell culture ,Head and Neck Neoplasms ,Cancer research ,Medicine ,Transcriptome ,Biomarkers - Abstract
Extracellular vesicles (EVs) are mediators of the immune system response. Encapsulated in EVs, microRNAs can be transferred between cancer and immune cells. To define the potential effects of EVs originated from squamous cell carcinoma cells on immune system response, we performed microRNA profiling of EVs released from two distinct cell lines and treated dendritic cells derived from circulating monocytes (mono-DCs) with these EVs. We confirmed the internalization of EVs by mono-DCs and the down-regulation of microRNA mRNA targets in treated mono-DCs. Differences in surface markers of dendritic cells cultivated in the presence of EVs indicated that their content disrupts the maturation process. Additionally, microRNAs known to interfere with dendritic cell function, and detected in EVs, matched microRNAs from squamous cell carcinoma patients’ plasma: miR-17-5p in oropharyngeal squamous cell carcinoma, miR-21 in oral squamous cell carcinoma, miR-16, miR-24, and miR-181a circulating in both oral and oropharyngeal squamous cell carcinoma, and miR-23b, which has not been previously described in plasma of head and neck squamous cell carcinoma, was found in plasma from patients with these cancer subtypes. This study contributes with insights on EVs in signaling between cancer and immune cells in squamous cell carcinoma of the head and neck.
- Published
- 2021